ADVM
$0.95
+$0.00 (+0.1%)
Closing price September 30, 2022
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
1 year ago
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
1 year ago
Last Updated: 1 year ago
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Ciena, CommVault Systems, Dollar General, JD.com, Kroger, Nucor, Target and Walmart.
2 years ago
Last Updated: 1 year ago
Adverum Bio shares dropped sharply on Thursday after the firm announced data from its Optic Phase 1 clinical trial in wet age-related macular degeneration.
3 years ago
Last Updated: 1 year ago
Adverum Biotechnologies shares made a handy gain on Thursday after the company announced a key update from the FDA.
4 years ago
Last Updated: 1 year ago